Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing study of human fibrinogen in congenital fibrinogen deficiency
CTR20241641Phase 4Completed
- Sponsor
- GC Biopharma
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Fibrinogen human in fibrinogen deficiency, congenital afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia, sponsored by GC Biopharma. Started May 2024; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
fibrinogen deficiencycongenital afibrinogenemiahypofibrinogenemiadysfibrinogenemia
Beyond the preview
Go deeper on CTR20241641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241641.